obesity drug news today glp-1 Are you eligible? Medicare's new Bridge program will cover certain weight-loss drugs starting this week. But as of now, the program isn't permanent: http://www.kvue.com/article/news/nation-world/medicare-covering-glp-1- weight-loss-drugs-bridge GLP-1 receptor gene variant boosts

Common Side Effects Both medications cause primarily gastrointestinal effects: Saxenda common side effects: Nausea (39%) Diarrhea (21%) Constipation (19%) Vomiting (16%) Injection site reactions (14%) Headache (14%) Dyspepsia (10%) Semaglutide common side effects: Nausea (44%) Diarrhea (30%) Vomiting (24%) Constipation (24%) Abdominal pain (20%) Headache (14%) Fatigue (11%) Side Effect Comparison Table Interpreting the Numbers Semaglutide appears to have higher rates of GI side effects in clinical trials

10.1002/smll.202408581 Small 46 QianZ.ChenH.XiaM.ChangJ.LiX.YeS.et al (2022)

This reflects a significant reduction from the $12,000 to $14,000 range cited in the Institute for Clinical and Economic Review's (ICER) 2022 evaluation

Read on to learn more about the common and rare side effects of these newer weight loss medications

Endocrinol Metab (Seoul) (2021) 36(1):229

American journal of physiology Cell physiology